AllianceBernstein’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
172,876
+72,840
+73% +$784K ﹤0.01% 2200
2026
Q1
$1.13M Buy
100,036
+3,800
+4% +$41.6K ﹤0.01% 2290
2025
Q4
$1.09M Sell
96,236
-156
-0.2% -$1.93K ﹤0.01% 2305
2025
Q3
$1.45M Buy
96,392
+156
+0.2% +$2.27K ﹤0.01% 2169
2025
Q2
$1.36M Hold
96,236
﹤0.01% 2128
2025
Q1
$2.31M Hold
96,236
﹤0.01% 1818
2024
Q4
$3.59M Buy
96,236
+5,951
+7% +$278K ﹤0.01% 1652
2024
Q3
$4.51M Sell
90,285
-6,900
-7% -$268K ﹤0.01% 1558
2024
Q2
$3.37M Sell
97,185
-12,346
-11% -$488K ﹤0.01% 1664
2024
Q1
$5.99M Sell
109,531
-54,202
-33% -$2.68M ﹤0.01% 1397
2023
Q4
$7.01M Buy
163,733
+34,563
+27% +$1.07M ﹤0.01% 1340
2023
Q3
$3.36M Buy
129,170
+59,652
+86% +$1.24M ﹤0.01% 1602
2023
Q2
$1.66M Sell
69,518
-500
-0.7% -$8.61K ﹤0.01% 2010
2023
Q1
$956K Buy
70,018
+34,000
+94% +$541K ﹤0.01% 2256
2022
Q4
$500K Buy
+36,018
New +$509K ﹤0.01% 2634

Other funds holding BHVN

AllianceBernstein's BHVN Position: Q2 2026 in Review

AllianceBernstein increased its Biohaven (BHVN) stake by 73% in Q2 2026, buying an estimated $784K and bringing the position to 172,876 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

AllianceBernstein first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.01M in Q4 2023. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • AllianceBernstein held 172,876 shares of Biohaven worth $1.46M as of Q2 2026.
  • AllianceBernstein bought 72,840 Biohaven shares in Q2 2026, an estimated $784K.
  • Biohaven made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2200 holding.
  • AllianceBernstein first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • AllianceBernstein's Biohaven position peaked at $7.01M in Q4 2023.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.